For example, it was reported that genetically-modified circulating CD11b+ cells (largely monocytes) were used to deliver and express the protease neprilysin gene into the CNS to arrest amyloid deposition in an Alzheimer’s disease transgenic murine model [82]. The gene discussed is ITGAM; the disease is Alzheimer disease.